Milan, Italy

Alessandro Martini


 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • Frazione Ponte S. Giovanni(Prov. Perugia), IT (1979)
  • Milan, IT (1992 - 2015)

Company Filing History:


Years Active: 1979-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alessandro Martini

Introduction

Alessandro Martini is a prominent inventor based in Milan, Italy, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in the development of anti-tumor compounds and their formulations.

Latest Patents

Among his latest patents is a pharmaceutical composition of an anthracycline, which relates to a composition containing nemorubicin hydrochloride incorporated in microspheres. This invention is particularly useful for chemoembolization, especially for the loco-regional treatment of tumors. Another notable patent involves oral formulations for anti-tumor compounds, which describes a semi-solid filling medium comprising a camptothecin derivative and a pharmaceutically acceptable carrier matrix, along with effective excipients for thickening and stabilizing.

Career Highlights

Throughout his career, Alessandro has worked with Pharmacia Italia S.p.a., where he has contributed to various innovative projects. His work has focused on enhancing the efficacy and delivery of pharmaceutical compounds, particularly in oncology.

Collaborations

Alessandro has collaborated with notable colleagues such as Lorena Muggetti and Paola Civaroli, further enriching his research and development efforts in the pharmaceutical industry.

Conclusion

Alessandro Martini's innovative work in pharmaceutical compositions and anti-tumor formulations highlights his significant impact on medical science. His contributions continue to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…